Generex Biotechnology Corporation Awarded Patent in Japan For Its Antigen Presentation Technology

WORCESTER, Mass., Dec. 18, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today that its wholly owned subsidiary, Antigen Express, Inc., has been awarded a Japanese patent strengthening its proprietary antigen presentation technology platform. The patent, entitled "Regulation of Antigen Presentation", strengthens specific aspects the Antigen Express peptide vaccine and immunomodulation technology.
MORE ON THIS TOPIC